List of works - Louise Nordfors

A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients.

scientific article published on May 2003

Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin

scientific article published in January 2004

Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients

scientific article published on 23 April 2007

Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study

scientific article

Associations between the CYBA 242C/T and the MPO –463G/A Polymorphisms, Oxidative Stress and Cardiovascular Disease in Chronic Kidney Disease Patients

scientific article published in 2007

CCR5 deletion protects against inflammation-associated mortality in dialysis patients

scientific article published on 23 April 2009

CDKN2A/p16INK4a expression is associated with vascular progeria in chronic kidney disease.

scientific article published on 9 February 2017

Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism

scientific article published on 18 October 2006

Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.

scientific article

Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.

scientific article

Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease

scientific article published on 3 December 2010

Genetic and clinical factors influence the baseline permeability of the peritoneal membrane

scientific article published in June 2005

Genetic approaches in the clinical investigation of complex disorders: malnutrition, inflammation, and atherosclerosis (MIA) as a prototype

scientific article

Genetic studies in chronic kidney disease: basic concepts

scientific article published on March 2012

Genetic studies in chronic kidney disease: interpretation and clinical applicability

scientific article

Genetics/Genomics in chronic kidney disease--towards personalized medicine?

scientific article published on July 2009

Genotypic and phenotypic predictors of inflammation in patients with chronic kidney disease

scientific article published on 19 April 2016

How can genetics and epigenetics help the nephrologist improve the diagnosis and treatment of chronic kidney disease patients?

scientific article published on 24 February 2014

Increased Telomere Attrition After Renal Transplantation-Impact of Antimetabolite Therapy.

scientific article published on 16 November 2016

Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification

scientific article published on 02 September 2015

Influence of cytokine gene polymorphisms on erythropoetin dose requirements in chronic haemodialysis patients

scientific article published on 25 August 2007

Influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with end-stage renal disease

scientific article published on 26 November 2009

Interleukin-1 Gene Cluster Polymorphisms Are Associated with Nutritional Status and Inflammation in Patients with End-Stage Renal Disease

scientific article published in 2005

Is UCP2 gene polymorphism associated with decreased resting energy expenditure in nondialyzed chronic kidney disease patients?

scientific article

Is fetuin-A a mortality risk factor in dialysis patients or a mere risk marker? A Mendelian randomization approach

scientific article published on 05 July 2010

Is fetuin-A/alpha2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?

scientific article published on 13 March 2008

Lipid disorders in chronic kidney disease: reverse epidemiology and therapeutic approach.

scientific article published on September 2008

Lipoprotein lipase 1595 c/g and hepatic lipase -480 c/t polymorphisms--impact on lipid profile in incident dialysis patients

scientific article published on 2 December 2008

Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin

article

Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease

scientific article published in July 2004

Reply from the Authors

scientific article published in December 2005

Selection of genetic and phenotypic features associated with inflammatory status of patients on dialysis using relaxed linear separability method

scientific article published on 28 January 2014

Telomere Attrition and Elongation after Chronic Dialysis Initiation in Patients with End-Stage Renal Disease

scientific article published on 20 October 2015

Understanding the role of genetic polymorphisms in chronic kidney disease.

scientific article published on 27 March 2008

Use of single-nucleotide polymorphisms in the search for genetic modifiers of the uremic phenotype

scientific article published on January 2007

Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels.

scientific article published on 30 November 2009

List of works by Louise Nordfors

A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients.

Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin

Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients

Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study

Associations between the CYBA 242C/T and the MPO –463G/A Polymorphisms, Oxidative Stress and Cardiovascular Disease in Chronic Kidney Disease Patients

CCR5 deletion protects against inflammation-associated mortality in dialysis patients

CDKN2A/p16INK4a expression is associated with vascular progeria in chronic kidney disease.

Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism

Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.

Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.

Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease

Genetic and clinical factors influence the baseline permeability of the peritoneal membrane

Genetic approaches in the clinical investigation of complex disorders: malnutrition, inflammation, and atherosclerosis (MIA) as a prototype

Genetic studies in chronic kidney disease: basic concepts

Genetic studies in chronic kidney disease: interpretation and clinical applicability

Genetics/Genomics in chronic kidney disease--towards personalized medicine?

Genotypic and phenotypic predictors of inflammation in patients with chronic kidney disease

How can genetics and epigenetics help the nephrologist improve the diagnosis and treatment of chronic kidney disease patients?

Increased Telomere Attrition After Renal Transplantation-Impact of Antimetabolite Therapy.

Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification

Influence of cytokine gene polymorphisms on erythropoetin dose requirements in chronic haemodialysis patients

Influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with end-stage renal disease

Interleukin-1 Gene Cluster Polymorphisms Are Associated with Nutritional Status and Inflammation in Patients with End-Stage Renal Disease

Is UCP2 gene polymorphism associated with decreased resting energy expenditure in nondialyzed chronic kidney disease patients?

Is fetuin-A a mortality risk factor in dialysis patients or a mere risk marker? A Mendelian randomization approach

Is fetuin-A/alpha2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?

Lipid disorders in chronic kidney disease: reverse epidemiology and therapeutic approach.

Lipoprotein lipase 1595 c/g and hepatic lipase -480 c/t polymorphisms--impact on lipid profile in incident dialysis patients

Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin

Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease

Reply from the Authors

Selection of genetic and phenotypic features associated with inflammatory status of patients on dialysis using relaxed linear separability method

Telomere Attrition and Elongation after Chronic Dialysis Initiation in Patients with End-Stage Renal Disease

Understanding the role of genetic polymorphisms in chronic kidney disease.

Use of single-nucleotide polymorphisms in the search for genetic modifiers of the uremic phenotype

Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels.